Mariner’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-16,404
Closed -$454K 3388
2024
Q3
$454K Buy
16,404
+1,141
+7% +$28.5K ﹤0.01% 2216
2024
Q2
$364K Buy
15,263
+1,217
+9% +$28.6K ﹤0.01% 2302
2024
Q1
$247K Buy
14,046
+1,015
+8% +$15K ﹤0.01% 2596
2023
Q4
$206K Sell
13,031
-1,905
-13% -$19.7K ﹤0.01% 2676
2023
Q3
$128K Buy
14,936
+1,400
+10% +$9.95K ﹤0.01% 2638
2023
Q2
$107K Buy
13,536
+2,743
+25% +$19.1K ﹤0.01% 2625
2023
Q1
$80K Sell
10,793
-2,469
-19% -$24.5K ﹤0.01% 2608
2022
Q4
$156K Buy
13,262
+2,340
+21% +$26.7K ﹤0.01% 2413
2022
Q3
$101K Buy
+10,922
New +$132K ﹤0.01% 2199
2022
Q2
Sell
-10,094
Closed -$349K 1377
2022
Q1
$349K Buy
+10,094
New +$328K ﹤0.01% 1249

Other funds holding ASPN

Mariner's ASPN Position: Q4 2024 in Review

Mariner sold out of Aspen Aerogels (ASPN) in Q4 2024, closing a stake of 16,404 shares — an estimated $454K sold.

Mariner first reported a position in ASPN in Q1 2022 and held it in 10 quarters. The position peaked at $454K in Q3 2024. 231 funds tracked by Wall St. Rank hold ASPN as of Q4 2024.

  • Mariner reported no remaining Aspen Aerogels position as of Q4 2024 after selling out during the quarter.
  • Mariner sold 16,404 Aspen Aerogels shares in Q4 2024, an estimated $454K.
  • Mariner first reported a position in Aspen Aerogels in Q1 2022 and held it in 10 quarters.
  • Mariner's Aspen Aerogels position peaked at $454K in Q3 2024.
  • 231 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2024.

Based on Mariner's 13F filing for Q4 2024, filed 13 Feb 2025.